
The study investigated the role of lncRNA MIR181A1HG in gastric cancer (GC) progression. MIR181A1HG is upregulated in GC and interacts with ELAVL1 to regulate epithelial-mesenchymal transition (EMT). Additionally, a positive feedback loop involving miR-181a-5p/miR-181b-5p, SOCS3, and NFATC2 enhances MIR181A1HG expression. MIR181A1HG expression correlates with key markers such as ELAVL1 and NFATC2 and negatively with SOCS3, suggesting its potential as a prognostic biomarker in GC.
Like
Save
Share